Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: TobagoJack who wrote (193122)	11/7/2022 4:10:21 AM
From: Arran Yuan	2 Recommendations Recommended By alanrs marcher Read Replies (1) \| Respond to of 217942

Dr. Yan's work focuses on cellular membrane-bound ion channel proteins and hetero-nuclear RNA splicesome (maturation of transcribed RNA into translatable mRNA), which are both essential biological process. Hence, they are mainly of pure academic value, but of very little, if any, practical use. Moreover, protein structure research employing AI carried out in another lab (at Washington U. in Seattle?) is much more productive and practical than hers. Interesting read about academia and competition, since Team Biden noted that biotech is a USA-China battlefield Competition should propel progress, so it is baffling to me as to what does 'battlefield' mean herein. Taking COVID-19 mRNA expressing fragment of S protein targeting ACE2 as an example, the background dot-dot straightline logic is even more troubling. Just like the flawed measure of national power merely by GDP, while everything else, such as debt, is omitted. Biology of life is a dynamic network of thousands of biochemical reactions in equilibrium, namely in a fashion of homeostasis, under integration of physiology, such as circulation, hormone, and, of course, nervous system. Biotech has to adopt systemic and dynamic approaches to be meaningfully helpful to enhance human health. In this sense, traditional medical intellectual properties, both western and oriental, have virtue and should be further developed. JMHO